These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19628283)

  • 1. The link between insulin resistance and preeclampsia: new perspectives.
    Scioscia M; Gumaa K; Rademacher TW
    J Reprod Immunol; 2009 Nov; 82(2):100-5. PubMed ID: 19628283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?
    Rademacher TW; Gumaa K; Scioscia M
    J Reprod Immunol; 2007 Dec; 76(1-2):78-84. PubMed ID: 17537518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels.
    Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW
    Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus.
    Scioscia M; Gumaa K; Selvaggi LE; Rodeck CH; Rademacher TW
    J Perinat Med; 2009; 37(5):469-71. PubMed ID: 19492925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a link between insulin resistance and inflammatory activation in preeclampsia?
    Scioscia M; Greco P; Selvaggi LE; Rademacher TW
    Med Hypotheses; 2009 Nov; 73(5):813-7. PubMed ID: 19443128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol phosphoglycans and preeclampsia: from bench to bedside.
    Scioscia M; Williams PJ; Gumaa K; Fratelli N; Zorzi C; Rademacher TW
    J Reprod Immunol; 2011 May; 89(2):173-7. PubMed ID: 21549431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
    Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW
    J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies.
    Scioscia M; Gumaa K; Whitten M; Selvaggi LE; Rodeck CH; Rademacher TW
    J Reprod Immunol; 2007 Dec; 76(1-2):85-90. PubMed ID: 17493685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational diabetes, pregnancy hypertension, and late vascular disease.
    Carpenter MW
    Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus.
    Scioscia M; Kunjara S; Gumaa K; McLean P; Rodeck CH; Rademacher TW
    Diabet Med; 2007 Nov; 24(11):1300-4. PubMed ID: 17956457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus.
    Scioscia M; Kunjara S; Gumaa K; Gomez Galan AM; McLean P; Rodeck CH; Rademacher TW
    Gynecol Obstet Invest; 2007; 64(4):217-23. PubMed ID: 17664885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance syndrome in preeclampsia.
    Kaaja R
    Semin Reprod Endocrinol; 1998; 16(1):41-6. PubMed ID: 9654606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder.
    Paine MA; Scioscia M; Williams PJ; Gumaa K; Rodeck CH; Rademacher TW
    Hypertens Pregnancy; 2010; 29(4):375-84. PubMed ID: 20701477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-chiro inositol phosphoglycans in preeclampsia: Where are we, where are we going?
    Scioscia M
    J Reprod Immunol; 2017 Nov; 124():1-7. PubMed ID: 28982033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy complications as a risk factor for metabolic and cardiovascular disease in later life].
    Sikkema JM; Bruinse HW; Visser GH; Franx A
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):898-902. PubMed ID: 16686089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus.
    Tomazic M; Janez A; Sketelj A; Kocijancic A; Eckel J; Sharma PM
    Diabetologia; 2002 Apr; 45(4):502-8. PubMed ID: 12032625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disorder of pregnancy (understanding pathophysiology of diabetes and preeclampsia).
    Salzer L; Tenenbaum-Gavish K; Hod M
    Best Pract Res Clin Obstet Gynaecol; 2015 Apr; 29(3):328-38. PubMed ID: 25481558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and the menopause.
    Kaaja RJ
    Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2.
    Scioscia M; Gumaa K; Kunjara S; Paine MA; Selvaggi LE; Rodeck CH; Rademacher TW
    J Clin Endocrinol Metab; 2006 Feb; 91(2):709-17. PubMed ID: 16332940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of diabetes mellitus.
    Haas LB
    Nurse Pract Forum; 1998 Jun; 9(2):42-5. PubMed ID: 9752116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.